Benitec, Tacere deal

Benitec will acquire RNAi company Tacere for about 102.3 million newly issued ordinary shares, which the companies valued

Read the full 180 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE